Portfolio

UROTEC Exit

UroTec’s MukoCell® made of autologous, in vitro cultured mucosa cells. Only a small biopsy needs to be taken from the patient.

Exit since August 2010.

Pressemeldungen

UroTec GmbH gains strategic partner – Profitable exit for High-Tech Gründerfonds and Technologiegründerfonds Sachsen

APOGEPHA Arzneimittel GmbH has, as strategic investor, purchased a majority stake in UroTec GmbH, acquiring the shares from the previous shareholders. The rich-in-tradition, Saxony-based APOGEPHA pharmaceuticals company is an established producer of urology drugs and the ideal partner for the innovative UroTec…
Read

Info & Contact

Address

Budapester Str.3
01069 Dresden

In portfolio

14. Feb 2008 – 25. Aug 2010
Exit